60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.070
0.00 (-0.01%)
Dec 3, 2024, 11:51 AM EST - Market open
SXTP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.46 | 0.25 | 0.51 | 6.35 | 2.55 |
| Revenue Growth (YoY) | 128.99% | -50.40% | -91.95% | 149.18% | - |
| Cost of Revenue | 4.89 | 1.17 | 0.96 | 6.36 | 1.51 |
| Gross Profit | -4.42 | -0.91 | -0.45 | -0.01 | 1.04 |
| Selling, General & Admin | 5.11 | 4.24 | 1.3 | 1.12 | 1.46 |
| Operating Expenses | 5.11 | 4.24 | 1.3 | 1.12 | 1.46 |
| Operating Income | -9.53 | -5.15 | -1.75 | -1.12 | -0.42 |
| Interest Expense | -0.01 | -2.29 | -3.99 | -3.17 | -2.63 |
| Other Non Operating Income (Expenses) | 1.64 | -0.47 | -0.56 | -0 | - |
| EBT Excluding Unusual Items | -7.9 | -7.91 | -6.3 | -4.3 | -3.05 |
| Other Unusual Items | -0.05 | 4.1 | 0.12 | 0.04 | - |
| Pretax Income | -7.95 | -3.81 | -6.18 | -4.26 | -3.05 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Earnings From Continuing Operations | -7.95 | -3.81 | -6.18 | -4.26 | -3.05 |
| Minority Interest in Earnings | 0.04 | 0.05 | -0 | 0.01 | 0.01 |
| Net Income | -7.91 | -3.77 | -6.18 | -4.25 | -3.03 |
| Net Income to Common | -8.17 | -3.77 | -6.18 | -4.25 | -3.03 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 19 | - |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 19 | - |
| Shares Change (YoY) | 360.73% | 67.26% | -98.95% | - | - |
| EPS (Basic) | -6.82 | -11.41 | -31.33 | -0.23 | - |
| EPS (Diluted) | -6.82 | -11.41 | -31.33 | -0.23 | - |
| Free Cash Flow | -4.23 | -4.6 | -1.01 | -0.65 | -0.17 |
| Free Cash Flow Per Share | -3.53 | -13.94 | -5.12 | -0.03 | - |
| Gross Margin | - | - | -87.39% | -0.14% | 40.78% |
| Operating Margin | -2060.75% | -2032.78% | -342.41% | -17.69% | -16.40% |
| Profit Margin | -1765.01% | -1485.06% | -1209.23% | -66.93% | -119.00% |
| Free Cash Flow Margin | -915.05% | -1814.28% | -197.57% | -10.27% | -6.56% |
| EBITDA | -9.49 | -5.1 | -1.72 | -1.09 | -0.39 |
| EBITDA Margin | - | - | - | -17.21% | -15.31% |
| D&A For EBITDA | 0.04 | 0.05 | 0.03 | 0.03 | 0.03 |
| EBIT | -9.53 | -5.15 | -1.75 | -1.12 | -0.42 |
| EBIT Margin | - | - | - | -17.69% | -16.40% |
Source: S&P Capital IQ. Standard template.
Financial Sources.